TAKEDA TAK-620-2004 SUBJECT
Medable Inc. Medical
A Phase 3 study for the treatment of CMV who have received a HSCT or SOT
- Downloads
- 1+
- on Google Play
- Price
- Free
- No in-app purchases
- Updated
- Jul 26
- 2022 · vv1.0.0
Screenshots
About TAKEDA TAK-620-2004 SUBJECT
A Phase 3, open-label, single-arm, repeated-dose
study to evaluate the safety and tolerability,
pharmacokinetics, and antiviral activity of
maribavir for the treatment of cytomegalovirus
(CMV) infection in children and adolescents who
have received a hematopoietic stem cell
transplant (HSCT) or a solid organ transplant
(SOT)
study to evaluate the safety and tolerability,
pharmacokinetics, and antiviral activity of
maribavir for the treatment of cytomegalovirus
(CMV) infection in children and adolescents who
have received a hematopoietic stem cell
transplant (HSCT) or a solid organ transplant
(SOT)
What’s new
Version v1.0.0 · Updated July 26, 2022
A Phase 3 study for the treatment of CMV who have received a HSCT or SOT
Alternatives to TAKEDA TAK-620-2004 SUBJECT
Looking for apps like TAKEDA TAK-620-2004 SUBJECT? Here are 6 similar Android apps on Google Play. The highest rated is Medable Participant App (4.4/5), and all 6 are free to download.
| App | Rating | Price | Installs | Last updated | Compare |
|---|---|---|---|---|---|
| TAKEDA TAK-620-2004 SUBJECT | – | Free | 1+ | Jul 26, 2022 | |
| Medable Participant App | 4.4 / 5 | Free | 10,000+ | – | Compare |
| I8F-MC-GPHJ PATIENT | – | Free | 0+ | Dec 9, 2022 | Compare |
| NN7769-4532 Participant | – | Free | 100+ | Apr 2, 2026 | Compare |
| CA055-026 | – | Free | 0+ | Nov 23, 2022 | Compare |
| CA116-001 | – | Free | 0+ | Oct 31, 2022 | Compare |
| BELIEVE | – | Free | 0+ | Oct 19, 2022 | Compare |
Similar apps on Google Play
- Medable Participant App
- I8F-MC-GPHJ PATIENT
- NN7769-4532 Participant
- CA055-026
- CA116-001
- BELIEVE
- CA116-003
- ZEAL Study
- TROPION-Lung07
- TROPION-Lung08 France
- CA209-6L6
- HERTHENA-Lung02-FR
- MyELEVATE
- Pins&Needles
- 18424-315
- NN8640-4467 Participant
- 5051-201: Patient
- Patient TAK-062-2001
- AFX3772-003 Patient App
- Tropion-Breast02
- HERTHENA-Lung02
- IPF COMFORT
- ASCENT1
- 849-EAP-001
- HYPERION ePRO (FR)
- Arbutus AB-729-202
- Soteria eDiary (FR)
- ADAURA2
- AZ Pacific-9
- NN7769-4516 Participant
- AZ Pacific-8
- RxKinect
- 037 Weekly Switch Study
- TROPION-Lung08
- Fulcrum Therapeutics SCD
- AZ Monette
- RVLO 121-04
- AEON 20002 EXT
- B Sure
- TROPION Breast01
- NN7769-4514 Participant
- Novartis CQGE031G12301 Patient
- ZEUS Study App (EX6018-4758)
- TVLite4482-013
- L606 eDiary App
- EmpPOWER
- SOTERIA eDiary
- Hibiscus Study: Pain Diary
- REALIZE-K
- Aeon 20001 Patient App
- DESTINY-Lung03
- DESTINY-Breast07
- DESTINY-PanTumor01
- AZ PETRA (D9720C00001)
- ArgenX Televisit
- DESTINY-Breast08
- Corrona PSO
- SAAVY (270-701)
- Denali TeleVisit
- MEDI5752 RCC Study
- Site Televisit
- Medable ACCESS
- YTB323
- Medable TeleVisit
- Dragon Study Patient App
- AZ HUDSON Blood Pressure
- SIGA Mobile Patient App
- AstraZeneca DKD (MEDI3506)
- SAMS-CI
- BGB-215 Wellbeing Activity App
- LOUiSSe
- STEP-1 Patient
- UControlPain
- PRISM-MDR
- Psoriasis LITE Patient